As per Quarterly DXB has several non binding term sheets, with multiple parties currently in the data room conducting due diligence and negotiating a potential licensing agreement, following the successful first interim analysis, I am not sure about the timeline here for completion of first interim analysis that's not clear from the announcement
- Forums
- ASX - By Stock
- Ann: Quarterly Appendix 4C and Activities Report
As per Quarterly DXB has several non binding term sheets, with...
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
39.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $217.5M |
Open | High | Low | Value | Volume |
39.0¢ | 39.5¢ | 38.0¢ | $444.0K | 1.151M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.5¢ | 7392 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.390 |
2 | 111814 | 0.385 |
5 | 104199 | 0.380 |
9 | 325516 | 0.375 |
14 | 531035 | 0.370 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 7392 | 1 |
0.400 | 24657 | 6 |
0.405 | 92627 | 2 |
0.410 | 144999 | 5 |
0.415 | 100000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online